Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Elisabetta Munzone; Giuseppe Curigliano; Andrea Rocca; Giuseppina Bonizzi; Giuseppe Renne; Aron Goldhirsch; Franco Nolè

doi:10.1186/bcr1366

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Breast Cancer Research ◽

10.1186/bcr1366 ◽

2005 ◽

Vol 8 (1) ◽

Cited By ~ 40

Author(s):

Elisabetta Munzone ◽

Giuseppe Curigliano ◽

Andrea Rocca ◽

Giuseppina Bonizzi ◽

Giuseppe Renne ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2 ◽

Estrogen Receptor Negative ◽

Negative Phenotype

Download Full-text

Erratum to: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

Breast Cancer Research ◽

10.1186/bcr1606 ◽

2006 ◽

Vol 8 (5) ◽

Cited By ~ 6

Author(s):

Elisabetta Munzone ◽

Giuseppe Curigliano ◽

Andrea Rocca ◽

Giuseppina Bonizzi ◽

Giuseppe Renne ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2 ◽

Estrogen Receptor Negative ◽

Negative Phenotype

Download Full-text

Abstract PS5-44: Pik3ca mutations among hormone receptor positive and HER-2 negative advanced breast cancer patients in Finland

10.1158/1538-7445.sabcs20-ps5-44 ◽

2021 ◽

Author(s):

Krista Heinolainen ◽

Silva Saarinen ◽

Antti Ellonen ◽

Antti Karlsson ◽

Meri Utriainen ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Pik3ca Mutations ◽

Hormone Receptor Positive ◽

Her 2

Download Full-text

Correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2+ Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy

The Oncologist ◽

10.1634/theoncologist.2011-0212erratum ◽

2013 ◽

Vol 18 (6) ◽

pp. 775-775

Author(s):

Renata Duchnowska ◽

Wojciech Biernat ◽

Barbara Szostakiewicz ◽

Jeff Sperinde ◽

Fanny Piette ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Protein Expression ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2

Download Full-text

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

Breast Cancer Research and Treatment ◽

10.1023/b:brea.0000036783.88387.47 ◽

2004 ◽

Vol 86 (3) ◽

pp. 197-206 ◽

Cited By ~ 44

Author(s):

A. Di Leo ◽

S. Chan ◽

M. Paesmans ◽

K. Friedrichs ◽

T. Pinter ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Single Agent ◽

Predictive Marker ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2

Download Full-text

Abstract P3-14-21: Phase II Study of Single Agent Trifunctional Antibody Ertumaxomab (Anti-HER-2 & Anti-CD3) in HER-2 Low Expressing Hormone-Refractory Advanced Breast Cancer Patients (ABC)

10.1158/0008-5472.sabcs10-p3-14-21 ◽

2010 ◽

Cited By ~ 4

Author(s):

F Cardoso ◽

L Dirix ◽

PF Conte ◽

V Semiglazov ◽

S de Placido ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2 ◽

Hormone Refractory

Download Full-text

Abstract P2-08-08: A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the18F-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients

10.1158/1538-7445.sabcs16-p2-08-08 ◽

2017 ◽

Author(s):

EGE de Vries ◽

CM Venema ◽

AWJM Glaudemans ◽

A Jager ◽

F Garner ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase 1 ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Phase 1 Study ◽

Er Positive

Download Full-text

Novel Approach for Evaluating and Treating Advanced Breast Cancer Patients Whose Tumors Overexpress HER-2/neu

10.21236/ada418094 ◽

2003 ◽

Author(s):

Michael J. Blend

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Novel Approach ◽

Her 2

Download Full-text

Correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2 + Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy

The Oncologist ◽

10.1634/theoncologist.2011-0212 ◽

2012 ◽

Vol 17 (1) ◽

pp. 26-35 ◽

Cited By ~ 25

Author(s):

Renata Duchnowska ◽

Wojciech Biernat ◽

Barbara Szostakiewicz ◽

Jeff Sperinde ◽

Fanny Piette ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Protein Expression ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2

Download Full-text

Novel Approach for Evaluating and Treating Advanced Breast Cancer Patients Whose Tumors Overexpress HER-2/neu

10.21236/ada407296 ◽

2002 ◽

Author(s):

Micahel J. Blend ◽

Steven M. Swanson ◽

Jeffrey Medin

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Novel Approach ◽

Her 2

Download Full-text

439 Correlation between efficacy of single-agent Trastuzumab (T) and molecular markers in HER-2 positive advanced breast cancer patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90471-x ◽

2003 ◽

Vol 1 (5) ◽

pp. S134

Author(s):

R. Giuliani ◽

V. Durbecq ◽

D. Larsimont ◽

L. Dirix ◽

J.-L. Canon ◽

...

Keyword(s):

Breast Cancer ◽

Molecular Markers ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Single Agent ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her 2

Download Full-text